MCHP finds itself in an unusual post-earnings tension: the Street just raised price targets across the board, the stock is up 37% over the past month — and short sellers are quietly adding to their positions at the fastest pace in weeks.
The analyst reaction to the May 7 earnings print was unambiguously constructive. Nearly every firm covering MCHP raised its target in the days that followed. JP Morgan's Harlan Sur lifted to $120 from $95. UBS moved to $130 from $115. Citi raised to $113. Evercore, Susquehanna, and Rosenblatt all revised higher. The direction of travel is clear: the post-earnings consensus is that MCHP is worth materially more than it was trading at a month ago. The mean price target now sits at $113.24, about 16% above Tuesday's close of $97.70. Cantor Fitzgerald reiterated Overweight with a $125 target as recently as today. Not a single firm cut its rating in the recent round of revisions, though Wells Fargo and Barclays hold at Equal-Weight, reflecting a more cautious view on near-term entry.
Where the story gets interesting is in the positioning data. Short interest has climbed to 5.7% of free float — a multi-week high — after rising more than 6% in the past week and nearly 22% over the past month. The acceleration is notable given the stock's strong price recovery. Shorts moved from roughly 4.6% of float in early April to where they are now, a build that closely tracks the post-tariff bounce rather than preceding it. Borrowing conditions give no indication of a squeeze developing: cost to borrow is running at just 0.53%, near its recent range lows, and availability remains relatively loose. The lending market is not stressed. This looks less like a conviction short and more like a hedging or mean-reversion position being layered on into strength.
Options traders are leaning the same way as the bulls. The put/call ratio at 0.41 is marginally below its 20-day average of 0.42, a near-neutral z-score of -0.34. At the 52-week low end of the range (52-week low is 0.36), call activity has been dominant for weeks. There is no defensive hedging spike — options positioning is calm and tilted toward the upside. That diverges from short interest, which is rising even as calls outpace puts. The two signals point in opposite directions, which is the tension worth watching.
The insider picture adds a further layer of caution. CEO Steve Sanghi sold approximately 526,000 shares across three transactions between April 23 and May 1, generating roughly $47 million in proceeds at prices between $88.50 and $93.60. These trades took place as the stock was recovering sharply from its April lows. Sanghi remains one of the largest individual shareholders at roughly 1.73% of the company, but the cluster of sales heading into and after earnings is a pattern institutional observers tend to track closely. The broader 90-day net insider position is a net sell of approximately $48 million. No buying activity of any size was reported in the recent period.
After the most recent earnings print on May 7, the stock fell 3.7% the following session — a pattern that also appeared after the February 5 report, when MCHP dropped 2.8% the day after before recovering to a small five-day gain. The recurring post-earnings dip suggests the market has had a habit of selling the news even when results meet expectations. With no next earnings date confirmed yet, the next near-term test is whether the stock can consolidate above $100 given the resumed short-building and the shadow cast by the CEO's recent sales programme.
See the live data behind this article on ORTEX.
Open MCHP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
